Skip to search formSkip to main contentSkip to account menu

Guanabenz

Known as: 2,6-Dichlorobenzylideneaminoguanidine, Guanabenzum, Guanabenzo 
An alpha-2 selective adrenergic agonist used as an antihypertensive agent.
National Institutes of Health

Related topics

Related topics

21 relations

Broader (2)

Adrenergic alpha-2 Receptor AgonistsAntihypertensive Agents
Adrenergic alpha2-Agonists [MoA]Breast Milk Secretion [PE]Decreased Blood Pressure [PE]Guanabenz Acetate

Narrower (5)

BR-750WY-8678Wytensinguanoxabenz

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
[3H]RX821002 (2-methoxyidazoxan) binds to alpha 2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney.
1995
1995
Recurrent laryngeal nerve activation by α2 adrenergic agonists in goats
1993
1993
Down-regulation of imidazoline sites in rabbit kidney.
1992
1992
Expression of Fos-like immunoreactivity by yohimbine and clonidine in the rat brain.
1988
1988
Effects of activating spinal α-adrenoreceptors on sympathetic nerve activity in the rat
1987
1987
Chronic clonidine treatment produces desensitisation of post- but not presynaptic alpha 2-adrenoceptors.
1986
1986
Alpha-adrenoceptor-mediated antinociception and sedation in the rat and dog
1984
1984
Treatment of the elderly hypertensive patient.
1977
1977
Guanabenz and methyldopa on hypertension and cardiac performance
In previous placebo‐controlled studies, guanabenz was shown to be a safe and effective antihypertensive drug without acute… 
1977
1977
Guanabenz in essential hypertension
Fifty‐five patients with mild to moderately severe essential hypertension were treated with guanabenz (2,6‐dichlorobenzylidene… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)